NEWSLETTER MARCH 2022

24 Mar 2022 · Jane Lowe

UniSeed: UniSuper makes first venture capital foray with $75m funding (afr.com)

UniSuper is making its first major foray into venture capital investing, tipping $75 million into the shared investment arm of the nation’s research agency, CSIRO, and four major Australian universi...

Read article
NEWSLETTER MARCH 2022

24 Mar 2022 · Michael Lovesey

Servatus launches new trial into the effects of live biotherapeutics on insomnia

Servatus CEO Dr Wayne Finlayson discusses the company’s new human clinical trial into the link between the gut microbiome and sleep by treating patients who suffer from insomnia with live…

Read article
NEWSLETTER MARCH 2022

24 Mar 2022 · Paul Langley

CEO in focus - Pureprofile's Martin Filz

We speak with Pureprofile's (ASX:PPL) inspirational leader, Martin Filz, about what makes him tick.

Read article
NEWSLETTER MARCH 2022

23 Mar 2022 · Paul Langley

Recent client coverage highlights

John Kelly spoke with Jack Crnjanin on Joy 94.9 Radio’s Well Well Well podcast about the Atomo HIV self-test and the health and awareness benefits to come from the TGA’s recent amendments to rules.

Read article
NEWSLETTER MARCH 2022

23 Mar 2022 · Cherie Hartley

Kazia begins phase II study into paxalisib + a keto diet to treat brain cancer

Kazia (ASX: KZA) CEO Dr James Garner discusses the enrolment of the first patient into their phase II study of paxalisib in combination with a ketogenic diet to treat glioblastoma (brain cancer)

Read article
NEWSLETTER MARCH 2022

21 Mar 2022 · Admin

Project: 2025

We are delighted to showcase a select number of emerging ASX listed tech companies on 31 March. The free virtual event will focus on companies that are paving the way forward with major advances in te...

Read article
NEWSLETTER MARCH 2022

17 Mar 2022 · Jane Lowe

XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference

XPON’s CEO Matt Forman's presentation to the ASX Small – Mid Cap CEO conference

Read article
UNCATEGORIZED

17 Mar 2022 · Paul Langley

Interview with Ben Fogarty, CEO (UK) XPON

Xpon's Ben Fogarty discusses the Metaverse from IR Department on Vimeo.

Read article
UNCATEGORIZED

16 Mar 2022 · Paul Langley

A groundbreaking approach to cancer treatment

Read article
NEWSLETTER MARCH 2022

16 Mar 2022 · Cherie Hartley

Race Oncology speaks to Proactive Investor as part of the ASX Small and Mid-Cap Conference

Race Oncology (ASX:RAC) CEO Phil Lynch provides an update on the Company’s activities and new strategy as part of their participation in the ASX Small and Mid-Cap Conference 2022.

Read article